Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid

Biological Psychiatry

Volumn 44, Issue 3, 1998, Pages 228-233

  Geracioti Jr , Thomas D ^a,b   Keck Jr , Paul E ^a   Ekhator, Nosa N ^a   West, Scott A ^a   Baker, Dewleen G ^a   Hill, Kelly K ^a   Bruce, Ann B ^a   Wortman, Matthew D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

5 hydroxyindoleacetic acid (5 HIAA); Cerebrospinal fluid (CSF); Dopamine; Homovanillic acid (HVA); HPLC; Human; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; MONOAMINE; SEROTONIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032146053     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)90372-3     Document Type: Article

References (29)

1. Agnati L.F., Zoli M., Stromberg I., Fuxe K. Intercellular communication in the brain Wiring versus volume transmission . Neuroscience. 69:1995;711-726.
2. Agren H., Mefford I.N., Rudorfer M.V., Linnoila M., Potter W.Z. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res. 20:1986;175-193.
3. Anderson I.M., Cowan P.J., Grahame-Smith D.G. Neuroendocrine and temperature response to gepirone in humans. Psychopharmacology. 100:1990;498-503.
4. Arya D.K. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry. 165:1994;728-733.
5. Bronzo M., Stahl S. Galactorrhea induced by sertraline. Am J Psychiatry. 150:1993;1269-1270.
6. Charney D.S., Heninger G.R., Reinhard J.F., Sternberg D.E., Hafstead K.M. The effects of intravenous l-tryptophan on prolactin, growth hormone, and mood in healthy subjects. Psychopharmacology. 77:1982;217-222.
7. Coulter D.M., Pillans P.I. Fluoxetine and extrapyramidal side effects. Am J Psychiatry. 15:1995;122-125.
8. Geracioti T.D. Jr, Orth D.N., Ekhator N.N., Blumenkopf B., Loosen P.T. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab. 74:1992;1325-1330.
9. Geracioti T.D. Jr, Nicholson W.E., Orth D.N., Ekhator N.N., Loosen P.T. Cholecystokinin in human cerebrospinal fluid Concentrations, dynamics, molecular forms, and relationship to fasting and feeding in health, depression and alcoholism . Brain Res. 629:1993;260-268.
10. Hsiao J.K., Potter W.Z., Agren H., Owen R.R., Pickar D. Clinical investigation of monoamine neurotransmitter interactions. Psychopharmacology. 112:1993;S76-S84.
11. Johnston J.P. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol. 17:1968;1285-1297.
12. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 153:1996;466-476.
13. Kennedy JS, Schmidt DE, Ebert MH, et al (1996): Diurnal and intrasubject variability in HVA, tryptophan and 5-HIAA levels in 24 hr serial lumbar CSF samples. International Society of Psychoneuroendocrinology XXVIIth Congress, General Program and Scientific Abstracts 83 (Abstract).
14. Kling MA, DeBellis MD, Geracioti Jr TD, et al (1997): Relationship of HVA and 5-HIAA in normal CSF measured hourly for 30 hours. Biol Psychiatry 41:41S (Abstract).
15. Kopin I.J. Monoamine oxidase and catecholamine metabolism. J Neural Transm. 41:(suppl):1994;57-67.
16. Lesaca T. Sertraline and galactorrhea. J Clin Psychopharmacol. 16:1996;333-334.
17. Lowy M.T., Meltzer H.Y. Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist. Biol Psychiatry. 23:1988;818-828.
18. MacIndoe J.H., Turkington R.W. Stimulation of human prolactin secretion by intravenous l-tryptophan. J Clin Invest. 52:1973;1972-1978.
19. Meltzer H.Y., Fleming R., Robertson A. The effect of buspirone on prolactin and growth hormone secretion in man. Arch Gen Psychiatry. 40:1983;1099-1102.
20. Meltzer H.Y. Clinical studies on the mechanism of action of clozapine The dopamine-serotonin hypothesis of schizophrenia . Psychopharmacology. 99:1989;S18-S27.
21. 2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull. 25:1989;390-392.
22. Mueller E., Murphy D.L., Sunderland T. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine evidence for a serotonin receptor-mediated mechanism of action in humans . Psychopharmacology. 98:1986;388-391.
23. Quattrone A., Tedeschi A., Aguglia U., Scopacasa F., Direnzo G.F., Annunziato L. Prolactin secretion in man A useful tool with which to evaluate the activity of drugs on central 5-hydroxytryptamine neurones: studies with fenfluramine . Br J Clin Pharmacol Exp Ther. 16:1983;471-475.
24. Roth BL and Meltzer HY (1995): The role of serotonin in schizophrenia In: Bloom FE, Kupfer DJ, editors, Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 1215-1227.
25. Shih J.C., Chen K. The expression of human MAO-A and B genes. J Neural Transm. 32:1990;41-47.
26. Silver R., LeSauter J., Tresco P.A., Lehman M.N. A diffusible coupling signal from transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature. 382:1996;810-813.
27. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R. 1990;American Psychiatric Press, Washington, DC.
28. Steur E.N.H.J. Increase of Parkinson disability after fluoxetine medication. Neurology. 43:1993;211-213.
29. Wood J.H. Physiology, pharmacology, and dynamics of cerebrospinal fluid. Wood J.H. Neurobiology of Cerebrospinal Fluid. 1980;1-16 Plenum Press, New York.